Jennifer Champoux's most recent trade in Monte Rosa Therapeutics Inc was a trade of 4,351 Common Stock done at an average price of $4.0 . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.98 per share. | 15 Jul 2026 | 4,351 | 66,722 | - | 4.0 | 17,317 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | 15 Jul 2026 | 4,351 | 26,947 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.38 per share. | 15 Jul 2026 | 4,351 | 62,371 | - | 23.4 | 101,730 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 23 Jun 2026 | 2,175 | 62,371 | - | 20 | 43,500 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | 23 Jun 2026 | 2,175 | 31,298 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.98 per share. | 23 Jun 2026 | 2,175 | 64,546 | - | 4.0 | 8,657 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 17 Jun 2026 | 2,176 | 62,371 | - | 19 | 41,344 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.98 per share. | 17 Jun 2026 | 2,176 | 64,547 | - | 4.0 | 8,660 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | 17 Jun 2026 | 2,176 | 33,473 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.98 per share. | 27 May 2026 | 2,175 | 64,546 | - | 4.0 | 8,657 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 27 May 2026 | 2,175 | 62,371 | - | 20 | 43,500 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | 27 May 2026 | 2,175 | 35,649 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.98 per share. | 22 May 2026 | 2,176 | 64,547 | - | 4.0 | 8,660 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | 22 May 2026 | 2,176 | 37,824 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 22 May 2026 | 2,176 | 62,371 | - | 19 | 41,344 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | 02 Jan 2026 | 158,000 | 158,000 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 35,000 | 65,000 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 02 Jan 2026 | 2,629 | 62,371 | - | 15.2 | 39,882 | Common Stock |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | 02 Jan 2025 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 30,000 | 30,000 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Ms. Jennifer Champoux | Chief Operating Officer | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |